AXIM BIOTECHNOLOGIES, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Axim Biotechnologies, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • Axim Biotechnologies, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 294M shares, a 29.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 294M +66.8M +29.3% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 278M +54.8M +24.5% Mar 31, 2024 10-Q/A 2024-05-22
Q4 2023 246M +53.5M +27.8% Dec 31, 2023 10-Q 2024-08-19
Q3 2023 238M +52.2M +28.2% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 228M +65M +39.9% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 224M +72.1M +47.6% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 192M +54.3M +39.4% Dec 31, 2022 10-K 2024-04-16
Q3 2022 185M +49.6M +36.5% Sep 30, 2022 10-Q/A 2022-11-15
Q2 2022 163M +29.7M +22.3% Jun 30, 2022 10-Q 2022-08-16
Q1 2022 152M +24M +18.8% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 138M +12.8M +10.2% Dec 31, 2021 10-K 2023-04-17
Q3 2021 136M +10.7M +8.54% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 133M +19.9M +17.6% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 128M +4.22M +3.42% Mar 31, 2021 10-Q/A 2021-06-02
Q4 2020 125M +60.5M +93.2% Dec 31, 2020 10-K/A 2022-04-19
Q3 2020 125M +62.4M +99.4% Sep 30, 2020 10-Q/A 2020-11-27
Q2 2020 113M +51.3M +83% Jun 30, 2020 10-Q/A 2020-08-18
Q1 2020 123M +62.2M +102% Mar 31, 2020 10-Q/A 2020-07-02
Q4 2019 64.9M +5.27M +8.85% Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 62.8M +4.12M +7.02% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 61.8M +4.3M +7.47% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 61.1M +4.41M +7.78% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 59.6M +5.02M +9.2% Dec 31, 2018 10-K/A 2020-05-20
Q3 2018 58.7M +4.1M +7.52% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 57.5M +4.97M +9.46% Jun 30, 2018 10-Q/A 2018-08-17
Q1 2018 56.7M +4.1M +7.8% Mar 31, 2018 10-Q/A 2018-05-18
Q4 2017 54.6M +2.06M +3.92% Dec 31, 2017 10-K 2019-04-08
Q3 2017 54.6M +3.07M +5.97% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 52.6M +10.8M +25.8% Jun 30, 2017 10-Q/A 2017-09-14
Q1 2017 52.6M +12.8M +32.2% Mar 31, 2017 10-Q/A 2017-09-14
Q4 2016 52.5M +12.9M +32.5% Dec 31, 2016 10-K 2018-03-15
Q3 2016 51.5M +12.1M +30.8% Sep 30, 2016 10-Q/A 2016-11-30
Q2 2016 41.8M +2.46M +6.25% Jun 30, 2016 10-Q/A 2016-08-25
Q1 2016 39.8M +6.74M +20.4% Mar 31, 2016 10-Q/A 2016-05-26
Q4 2015 39.6M +6.63M +20.1% Dec 31, 2015 10-K/A 2017-09-14
Q3 2015 39.4M +6.36M +19.3% Sep 30, 2015 10-Q 2015-11-23
Q2 2015 39.3M +6.34M +19.2% Jun 30, 2015 10-Q/A 2015-08-27
Q1 2015 33M +18K +0.06% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 33M 0 0% Dec 31, 2014 10-K/A 2016-04-18
Q3 2014 33M 0 0% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 33M 0 0% Jun 30, 2014 10-Q/A 2014-08-26
Q1 2014 33M 0 0% Mar 31, 2014 10-Q/A 2014-06-18
Q4 2013 33M 0 0% Dec 31, 2013 10-K 2015-04-14
Q3 2013 33M 0 0% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 33M 0 0% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 33M 0 0% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 33M 0 0% Dec 31, 2012 10-K 2014-03-04
Q3 2012 33M 0 0% Sep 30, 2012 10-Q 2012-11-19
Q2 2012 33M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 33M Mar 31, 2012 10-Q 2012-05-17
Q4 2011 33M 0 0% Dec 31, 2011 10-K 2013-04-15
Q3 2011 33M Sep 30, 2011 10-Q/A 2011-11-21
Q4 2010 33M Dec 31, 2010 10-K/A 2012-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.